Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Parkinson's Disease (INI-PD)
NCT04251585Phase 2Completed
- Sponsor
- HealthPartners Institute
- Start
- Feb 2020
- Primary completion
- Aug 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of intranasal insulin in Parkinson's disease (PD), sponsored by HealthPartners Institute. Started Feb 2020; status: completed.
02
Drugs
intranasal insulin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04251585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04251585.